research Recomendaciones Rama de Dermatología Pediátrica, Sociedad Chilena de Pediatría. Pandemia COVID-19
The document's conclusion cannot be provided because the document itself is not accessible or cannot be parsed.
Search
for
Sort by
Research
900-930 / 1000+ resultsresearch Ivarmacitinib stimulates hair regrowth in severe alopecia areata
Ivarmacitinib effectively regrows hair in severe alopecia areata.
research ISHRS Best Practices Survey Project MODULE: Anesthesia and Emergency SUMMARY ANALYSIS
research Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagogue
research Hair Restoration
I'm sorry, but I can't provide a summary without the document's content.
research Purpose-limited pharmaceutical product claims under the revised European Patent Convention: A camouflaged attack on generic substitution?
The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.
research ANÁLISE MICROBIOLÓGICA DE MATÉRIAS-PRIMAS E FORMULAÇÕES DE UMA FARMÁCIA DE MANIPULAÇÃO NA CIDADE DE VENÂNCIO AIRES/RS
The compounding pharmacy in Venâncio Aires generally follows good practices, with only the Paracetamol sample showing significant microbial growth.
research Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.
research 16799 Similar efficacy of maintenance treatment of finasteride 1 mg every other month compared with finasteride 1 mg daily in Korean men with androgenetic alopecia after taking finasteride 1 mg daily for 1 year
Finasteride 1 mg every other month works as well as daily dose for hair loss maintenance.
research Message from the Program Chair of the 2008 Annual Scientific Meeting
I'm sorry, but I can't provide a summary without the content of the document.
research Co-Editors’ Messages
The document's content cannot be parsed or understood.
research Hard Keratin IF and Associated Proteins
research Cover Image
research 44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
research Hair Transplant
research Hair Transplant
research Special collection on inward rectifying K+ channels
Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.
research Laser-Guided Hairline Design and Donor Strip Marking
The document's conclusion cannot be provided as the content is not available.
research Donor removal–sterile technique
The document's conclusion cannot be determined.
research Implementation of the JCCP Premises Standards for cosmetic interventions
The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.
research Hair loss in the elderly
The document's conclusion cannot be provided because the document is not readable.
research NUDT15,FTO, andRUNX1genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.
research Meeting Review
The document could not be processed for a summary.
research 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.
research Studies on a hair growth stimulant,procyanidin B-2
research Hair Sciences
The document's conclusion cannot be determined.
research Hair Sciences
The document's conclusion cannot be determined.
research INNOVATIVE APPROACHES TO SUPPORTING CLIENTS WITH ALOPECIA: INTEGRATION OF TRICHOLOGY AND BARBERING PRACTICES
research Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's disease
The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.
research Abstracts for IMANA Pre-ISNA Convention, September 2006
The document's content could not be processed.